Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion type Assertion NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_head.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion description "[The CFTR 5T polymorphism was identified in 31 of 334 (9.3%) patients of sporadic pancreatic cancer, in 5 of 43 (11.6%) patients with familial pancreatic cancer and in 10 of 112 (8.9%) controls with colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_provenance.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion evidence source_evidence_literature NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_provenance.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion SIO_000772 14688470 NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_provenance.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion wasDerivedFrom befree-20140225 NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_provenance.
- NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_assertion wasGeneratedBy ECO_0000203 NP627217.RAC1BBBX9pYAKcenokdhksF1sktM-GQ9lz1FvqfkBLMwI130_provenance.